Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Oral immunization against chlamydial eye infection.

Taylor HR, Young E, MacDonald AB, Schachter J, Prendergast RA.

Invest Ophthalmol Vis Sci. 1987 Feb;28(2):249-58.

PMID:
8591904
2.

A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.

Campos M, Pal S, O'Brien TP, Taylor HR, Prendergast RA, Whittum-Hudson JA.

Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1477-91.

PMID:
7601629
3.

Oral immunization with chlamydial major outer membrane protein (MOMP).

Taylor HR, Whittum-Hudson J, Schachter J, Caldwell HD, Prendergast RA.

Invest Ophthalmol Vis Sci. 1988 Dec;29(12):1847-53.

PMID:
3192374
4.

Attempted oral immunization with chlamydial lipopolysaccharide subunit vaccine.

Taylor HR, Prendergast RA.

Invest Ophthalmol Vis Sci. 1987 Oct;28(10):1722-6.

PMID:
3308760
6.
7.
9.

A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.

Murdin AD, Su H, Manning DS, Klein MH, Parnell MJ, Caldwell HD.

Infect Immun. 1993 Oct;61(10):4406-14.

10.

Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.

Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K.

Vaccine. 2006 Feb 20;24(8):1213-24. Epub 2005 Sep 12.

PMID:
16194585
11.

Development of immunity to ocular chlamydial infection.

Taylor HR.

Am J Trop Med Hyg. 1990 Apr;42(4):358-64.

PMID:
2331044
12.

Systemic immunization with Hsp60 alters the development of chlamydial ocular disease.

Rank RG, Dascher C, Bowlin AK, Bavoil PM.

Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1344-51.

PMID:
7775112
13.

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.

Whittum-Hudson JA, Rudy D, Gèrard H, Vora G, Davis E, Haller PK, Prattis SM, Hudson AP, Saltzman WM, Stuart ES.

Vaccine. 2001 Jul 16;19(28-29):4061-71.

PMID:
11427283
14.

Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.

Whittum-Hudson JA, An LL, Saltzman WM, Prendergast RA, MacDonald AB.

Nat Med. 1996 Oct;2(10):1116-21.

PMID:
8837610
15.

Immune response of owl monkeys to topical vaccination with irradiated Chlamydia trachomatis.

MacDonald AB, McComb D, Howard L.

J Infect Dis. 1984 Mar;149(3):439-42.

PMID:
6715899
16.

Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization.

Schautteet K, De Clercq E, Jönsson Y, Lagae S, Chiers K, Cox E, Vanrompay D.

Vaccine. 2012 Apr 16;30(18):2869-81. doi: 10.1016/j.vaccine.2012.02.044. Epub 2012 Mar 3.

PMID:
22387629
17.

Changes in conjunctival lymphocyte populations induced by oral immunization with Chlamydia trachomatis.

Whittum-Hudson JA, Prendergast RA, Taylor HR.

Curr Eye Res. 1986 Dec;5(12):973-9.

PMID:
3492335
18.
19.

Murine model of ocular infection by a human biovar of Chlamydia trachomatis.

Whittum-Hudson JA, O'Brien TP, Prendergast RA.

Invest Ophthalmol Vis Sci. 1995 Sep;36(10):1976-87.

PMID:
7657540

Supplemental Content

Support Center